Bryant Furlow

Bryant Furlow is medical journalist working at the crossroads of research, clinical practice, and public policy. His work has appeared The Lancet, New Scientist, and Oncology Nurse Advisor.

Most Recent Articles by Bryant Furlow

Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing

Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing

By

"People have shown that the variant-identification quality of WGS is superior to WES," said Dr Gerstein.

Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves

Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves

By

Patient-reported outcomes, or PROs, are going to play a larger role in FDA cancer drug approvals, according to an expert in the field.

A Common Factor Links Mechanisms of Acquired Resistance to Melanoma Treatment

A Common Factor Links Mechanisms of Acquired Resistance to Melanoma Treatment

By

Inhibition of ER translocation prevented both ERK reactivation and autophagy, suggesting a potential strategy for improving BRAF and MEK inhibition therapy outcomes.

Lenalidomide Maintenance Therapy for Multiple Myeloma

Lenalidomide Maintenance Therapy for Multiple Myeloma

By

Results from the phase 3 Myeloma XI trial bolster earlier evidence that maintenance therapy with lenalidomide is associated with improved PFS for some patients with multiple myeloma.

Could Cytostatic Drugs Unleash Antitumor Immunity in Lung Cancer?

Could Cytostatic Drugs Unleash Antitumor Immunity in Lung Cancer?

By

The combination of trametinib and palbociclib induced attack by NK cells — but not killing — of xenograft lung tumors in lab animals.

More Articles by Bryant Furlow

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs